| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Shayna Sharma | Q47134070 |
| John D Hooper | Q56955728 | ||
| Lewis Perrin | Q63968343 | ||
| P2093 | author name string | Gregory E Rice | |
| Carlos Salomon | |||
| Felipe Zuñiga | |||
| P2860 | cites work | Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis | Q24307717 |
| Rab27a and Rab27b control different steps of the exosome secretion pathway | Q24336455 | ||
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
| Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200 | Q24616100 | ||
| Predictive value of symptoms for early detection of ovarian cancer | Q24644590 | ||
| The role of CA125 in clinical practice | Q24672539 | ||
| B lymphocytes secrete antigen-presenting vesicles | Q24678522 | ||
| Effect of Screening on Ovarian Cancer Mortality | Q26253810 | ||
| Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges | Q26740577 | ||
| The potential of tumor-derived exosomes for noninvasive cancer monitoring | Q26796396 | ||
| Clinical epidemiology of epithelial ovarian cancer in the UK | Q26822648 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor | Q28238644 | ||
| Exosomes: from biogenesis and secretion to biological function | Q28270550 | ||
| Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes) | Q28301329 | ||
| Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells | Q28535417 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 | ||
| Isolation and characterization of exosomes from cell culture supernatants and biological fluids | Q29615035 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles | Q29620600 | ||
| Assessing the genetic architecture of epithelial ovarian cancer histological subtypes | Q30276986 | ||
| Formation and role of exosomes in cancer | Q30303067 | ||
| Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer | Q30841262 | ||
| Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer | Q33484414 | ||
| MicroRNAs: tools for cancer diagnostics | Q33575602 | ||
| Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts | Q39477145 | ||
| Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity | Q39616716 | ||
| Corrigendum: Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol. | Q39619655 | ||
| Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. | Q40075206 | ||
| Proinvasive properties of ovarian cancer ascites-derived membrane vesicles | Q40507973 | ||
| Adhesion and signaling by B cell-derived exosomes: the role of integrins | Q40570851 | ||
| Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface | Q40867441 | ||
| Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro | Q40941275 | ||
| Challenges in using circulating miRNAs as cancer biomarkers | Q41072824 | ||
| Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey | Q41643859 | ||
| Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating | Q41891729 | ||
| The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling | Q41903415 | ||
| Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue | Q42176384 | ||
| The immune score as a new possible approach for the classification of cancer | Q42539190 | ||
| Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells | Q46317943 | ||
| Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. | Q52844139 | ||
| The Effect of Glucose on the Release and Bioactivity of Exosomes From First Trimester Trophoblast Cells. | Q53395819 | ||
| Ovarian cancer | Q54105461 | ||
| The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform | Q54997659 | ||
| Pathology and classification of ovarian tumors | Q73357578 | ||
| Ovarian cancer screening | Q79881968 | ||
| Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells | Q80396444 | ||
| Ovarian cancer is a heterogeneous disease | Q81065708 | ||
| Circulating microparticles in patients with benign and malignant ovarian tumors | Q84150176 | ||
| Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer | Q87442434 | ||
| Ovarian cancer | Q88195269 | ||
| The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer | Q33691489 | ||
| MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress | Q33713506 | ||
| Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker | Q33790229 | ||
| Ovarian cancer: pathology, biology, and disease models | Q33807748 | ||
| Interaction and uptake of exosomes by ovarian cancer cells | Q33856501 | ||
| CA125 in ovarian cancer | Q33859857 | ||
| Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology. | Q33872622 | ||
| Hematogenous metastasis of ovarian cancer: rethinking mode of spread | Q33908024 | ||
| Ovarian cancer development and metastasis | Q34086819 | ||
| Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies | Q34273433 | ||
| Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies | Q34313269 | ||
| Characterization and proteomic analysis of ovarian cancer-derived exosomes | Q34323461 | ||
| Standardization of sample collection, isolation and analysis methods in extracellular vesicle research | Q34369038 | ||
| Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles | Q34455456 | ||
| Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication | Q34634997 | ||
| Biomarkers for screening, diagnosis, and monitoring of ovarian cancer | Q34642337 | ||
| MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons | Q34685896 | ||
| Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis | Q34827507 | ||
| Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer | Q35040690 | ||
| Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer | Q35273351 | ||
| FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication | Q35419216 | ||
| Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence | Q35644167 | ||
| Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. | Q35763548 | ||
| Therapeutic strategies in epithelial ovarian cancer | Q35845484 | ||
| High-grade ovarian cancer secreting effective exosomes in tumor angiogenesis | Q35854059 | ||
| Optimized exosome isolation protocol for cell culture supernatant and human plasma | Q35867005 | ||
| Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio | Q35904011 | ||
| Ovarian cancer metastasis: integrating insights from disparate model organisms | Q36111930 | ||
| Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures | Q36139088 | ||
| BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group | Q36145443 | ||
| High LIN28A Expressing Ovarian Cancer Cells Secrete Exosomes That Induce Invasion and Migration in HEK293 Cells | Q36259857 | ||
| Quantitative analysis of cell-free DNA in ovarian cancer | Q36334715 | ||
| A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. | Q36510465 | ||
| Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis | Q36511698 | ||
| Mechanisms of transcoelomic metastasis in ovarian cancer. | Q36643128 | ||
| The BOADICEA model of genetic susceptibility to breast and ovarian cancer | Q36695832 | ||
| Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. | Q36764656 | ||
| Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. | Q36929092 | ||
| Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers | Q37154428 | ||
| Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients | Q37295775 | ||
| Ovarian cancer: genomic analysis. | Q37332480 | ||
| Beyond chemotherapy: targeted therapies in ovarian cancer | Q37399899 | ||
| Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells | Q37483696 | ||
| Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy | Q37507018 | ||
| Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages | Q37536480 | ||
| Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration | Q37684424 | ||
| Exosomes as mediators of platinum resistance in ovarian cancer | Q37707018 | ||
| Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study | Q37716375 | ||
| Recent advances on the role of tumor exosomes in immunosuppression and disease progression | Q37988647 | ||
| Tumor markers in clinical practice: a review focusing on common solid cancers | Q38010046 | ||
| Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery | Q38025203 | ||
| The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis | Q38032281 | ||
| Exosomes: new players in cell-cell communication. | Q38035709 | ||
| Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review | Q38109551 | ||
| Monitoring the immune competence of cancer patients to predict outcome | Q38184391 | ||
| A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy | Q38205662 | ||
| Biogenesis and secretion of exosomes. | Q38222777 | ||
| Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment. | Q38260666 | ||
| Circulating microRNA biomarker studies: pitfalls and potential solutions | Q38267750 | ||
| The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles | Q38532967 | ||
| Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells | Q38739716 | ||
| Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery | Q38773416 | ||
| Exosomes: Potential in Cancer Diagnosis and Therapy | Q38810718 | ||
| Exosome-derived miRNAs and ovarian carcinoma progression | Q38985333 | ||
| In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome | Q39033791 | ||
| A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. | Q39042566 | ||
| Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. | Q39108824 | ||
| P433 | issue | 61 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 104687-104703 | |
| P577 | publication date | 2017-10-31 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression | |
| P478 | volume | 8 |
| Q91783978 | Multiplexed immunophenotyping of circulating exosomes on nano-engineered ExoProfile chip towards early diagnosis of cancer |
| Q64957921 | Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. |
| Q58741629 | The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications |
Search more.